Group One Trading
KRYS icon

Group One Trading’s Krystal Biotech KRYS Stock Holding History

Group One Trading’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,500
Closed -$3.27M – 8679
2025
Q3 		$3.27M Buy
18,500
+9,500
+106% +$1.42M 0.01% 1869
2025
Q2 		$1.24M Buy
+9,000
New +$1.32M ﹤0.01% 2575
2024
Q4 		– Sell
-1,000
Closed -$182K – 7633
2024
Q3 		$182K Hold
1,000
– – ﹤0.01% 3705
2024
Q2 		$184K Sell
1,000
-10,200
-91% -$1.71M ﹤0.01% 3467
2024
Q1 		$1.99M Buy
11,200
+9,700
+647% +$1.35M 0.01% 1483
2023
Q4 		$186K Sell
1,500
-600
-29% -$66.5K ﹤0.01% 3931
2023
Q3 		$244K Buy
2,100
+800
+62% +$97.6K ﹤0.01% 3637
2023
Q2 		$153K Sell
1,300
-5,400
-81% -$551K ﹤0.01% 4213
2023
Q1 		$536K Sell
6,700
-5,000
-43% -$393K ﹤0.01% 2716
2022
Q4 		$927K Buy
11,700
+10,900
+1,363% +$809K ﹤0.01% 2486
2022
Q3 		$56K Sell
800
-17,400
-96% -$1.26M ﹤0.01% 5309
2022
Q2 		$1.2M Buy
18,200
+13,400
+279% +$834K ﹤0.01% 2575
2022
Q1 		$319K Sell
4,800
-2,500
-34% -$156K ﹤0.01% 4308
2021
Q4 		$511K Buy
7,300
+7,000
+2,333% +$407K ﹤0.01% 4106
2021
Q3 		$16K Sell
300
-1,100
-79% -$65.1K ﹤0.01% 7291
2021
Q2 		$95K Buy
+1,400
New +$97.7K ﹤0.01% 6019

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's KRYS Position: Q4 2025 in Review

Group One Trading sold out of Krystal Biotech (KRYS) in Q4 2025, closing a stake of 160 shares — an estimated $33.7K sold.

Group One Trading first reported a position in KRYS in Q2 2020 and held it in 7 quarters. The position peaked at $212K in Q1 2024. 334 funds tracked by Wall St. Rank hold KRYS as of Q4 2025.

  • Group One Trading reported no remaining Krystal Biotech position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 160 Krystal Biotech shares in Q4 2025, an estimated $33.7K.
  • Group One Trading first reported a position in Krystal Biotech in Q2 2020 and held it in 7 quarters.
  • Group One Trading's Krystal Biotech position peaked at $212K in Q1 2024.
  • 334 funds tracked by Wall St. Rank held Krystal Biotech as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.